Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03062 |
| Species: | Homo sapiens |
| Position : | chr8:128747000-128748000 |
| Year: | 2020 |
| Title: | Transcription imparts architecture, function and logic to enhancer units. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 32958950 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | K-562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay; Enhancer activity assay; Endogenous enhancer perturbation |
| High Throughput Method: | ChIP-seq, ATAC-seq, RNA-seq; MPRA |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR Knockout, RT-RT-qPCR; CRISPR-Cas9 endogenous deletion/editing; Reporter assay |
| Target gene : | MYC |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|